3-37533460-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002207.3(ITGA9):​c.1520G>A​(p.Gly507Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.578 in 1,613,482 control chromosomes in the GnomAD database, including 274,594 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.55 ( 23851 hom., cov: 32)
Exomes 𝑓: 0.58 ( 250743 hom. )

Consequence

ITGA9
NM_002207.3 missense

Scores

1
8
9

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 7.88

Publications

41 publications found
Variant links:
Genes affected
ITGA9 (HGNC:6145): (integrin subunit alpha 9) This gene encodes an alpha integrin. Integrins are heterodimeric integral membrane glycoproteins composed of an alpha chain and a beta chain that mediate cell-cell and cell-matrix adhesion. The protein encoded by this gene, when bound to the beta 1 chain, forms an integrin that is a receptor for VCAM1, cytotactin and osteopontin. Expression of this gene has been found to be upregulated in small cell lung cancers. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.7952218E-6).
BP6
Variant 3-37533460-G-A is Benign according to our data. Variant chr3-37533460-G-A is described in ClinVar as Benign. ClinVar VariationId is 402989.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.792 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ITGA9NM_002207.3 linkc.1520G>A p.Gly507Glu missense_variant Exon 14 of 28 ENST00000264741.10 NP_002198.2 Q13797Q8N6H6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ITGA9ENST00000264741.10 linkc.1520G>A p.Gly507Glu missense_variant Exon 14 of 28 1 NM_002207.3 ENSP00000264741.5 Q13797
ITGA9ENST00000422441.5 linkc.1520G>A p.Gly507Glu missense_variant Exon 14 of 16 1 ENSP00000397258.1 E9PDS3

Frequencies

GnomAD3 genomes
AF:
0.552
AC:
83873
AN:
151892
Hom.:
23825
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.463
Gnomad AMI
AF:
0.638
Gnomad AMR
AF:
0.634
Gnomad ASJ
AF:
0.499
Gnomad EAS
AF:
0.812
Gnomad SAS
AF:
0.406
Gnomad FIN
AF:
0.572
Gnomad MID
AF:
0.364
Gnomad NFE
AF:
0.579
Gnomad OTH
AF:
0.539
GnomAD2 exomes
AF:
0.583
AC:
146132
AN:
250708
AF XY:
0.570
show subpopulations
Gnomad AFR exome
AF:
0.467
Gnomad AMR exome
AF:
0.740
Gnomad ASJ exome
AF:
0.499
Gnomad EAS exome
AF:
0.813
Gnomad FIN exome
AF:
0.569
Gnomad NFE exome
AF:
0.575
Gnomad OTH exome
AF:
0.563
GnomAD4 exome
AF:
0.581
AC:
849080
AN:
1461472
Hom.:
250743
Cov.:
50
AF XY:
0.574
AC XY:
417278
AN XY:
727020
show subpopulations
African (AFR)
AF:
0.460
AC:
15387
AN:
33474
American (AMR)
AF:
0.724
AC:
32376
AN:
44694
Ashkenazi Jewish (ASJ)
AF:
0.496
AC:
12966
AN:
26134
East Asian (EAS)
AF:
0.793
AC:
31472
AN:
39688
South Asian (SAS)
AF:
0.407
AC:
35079
AN:
86228
European-Finnish (FIN)
AF:
0.566
AC:
30199
AN:
53352
Middle Eastern (MID)
AF:
0.421
AC:
2427
AN:
5766
European-Non Finnish (NFE)
AF:
0.589
AC:
654906
AN:
1111756
Other (OTH)
AF:
0.568
AC:
34268
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
19215
38429
57644
76858
96073
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18054
36108
54162
72216
90270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.552
AC:
83941
AN:
152010
Hom.:
23851
Cov.:
32
AF XY:
0.550
AC XY:
40868
AN XY:
74284
show subpopulations
African (AFR)
AF:
0.463
AC:
19182
AN:
41452
American (AMR)
AF:
0.635
AC:
9698
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.499
AC:
1731
AN:
3470
East Asian (EAS)
AF:
0.812
AC:
4178
AN:
5144
South Asian (SAS)
AF:
0.406
AC:
1951
AN:
4806
European-Finnish (FIN)
AF:
0.572
AC:
6053
AN:
10580
Middle Eastern (MID)
AF:
0.340
AC:
100
AN:
294
European-Non Finnish (NFE)
AF:
0.579
AC:
39330
AN:
67966
Other (OTH)
AF:
0.539
AC:
1137
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1875
3751
5626
7502
9377
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
714
1428
2142
2856
3570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.571
Hom.:
85415
Bravo
AF:
0.562
TwinsUK
AF:
0.595
AC:
2205
ALSPAC
AF:
0.587
AC:
2263
ESP6500AA
AF:
0.471
AC:
2077
ESP6500EA
AF:
0.580
AC:
4991
ExAC
AF:
0.571
AC:
69371
Asia WGS
AF:
0.579
AC:
2016
AN:
3478
EpiCase
AF:
0.562
EpiControl
AF:
0.569

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: 57% of total chromosomes in ExAC -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

ITGA9-related disorder Benign:1
Aug 02, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.36
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.31
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.032
T;T
Eigen
Uncertain
0.31
Eigen_PC
Uncertain
0.41
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.69
T;T
MetaRNN
Benign
0.0000018
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.6
.;M
PhyloP100
7.9
PrimateAI
Uncertain
0.58
T
PROVEAN
Uncertain
-4.0
D;D
REVEL
Benign
0.27
Sift
Benign
0.031
D;D
Sift4G
Uncertain
0.010
D;D
Polyphen
0.53
P;B
Vest4
0.31
MPC
0.40
ClinPred
0.054
T
GERP RS
5.9
Varity_R
0.53
gMVP
0.73
Mutation Taster
=74/26
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs267561; hg19: chr3-37574951; COSMIC: COSV53237444; API